Navigation Links
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
Date:5/1/2012

SAN DIEGO, May 1, 2012 /PRNewswire/ -- Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised its option associated with the existing Pfenex contractual relationship begun in July, 2010. This extends the contract supporting the development of a robust Pfēnex Expression Technology™ based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax. Pursuant to the contract, Pfenex will continue to develop an rPA-based anthrax vaccine from rPA produced in Pseudomonas fluorescens.  During the contract's base period, Pfenex demonstrated that a strongly immunogenic, stable and protective form of rPA could be expressed and recovered from the highly efficient fermentation of a strain of P. fluorescens engineered to produce rPA.

"We are pleased with the results and progress provided by Pfenex's recombinant platform technology to the production of a next generation anthrax vaccine," stated Bertrand C. Liang, Chief Executive Officer. "The exercise of this option by BARDA enables Pfenex and BARDA to continue our successful partnership sharing a common objective to develop an anthrax vaccine with a process capable of achieving the goals of the Strategic National Stockpile for the U.S. Government, including production, shelf life, and administration improvements."

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. OptiScan Biomedical Presents Study Results Demonstrating OptiScanners Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients
2. Biospace Lab and the Centre for Advanced Biomedical Imaging at University College London to Collaborate on Development of Novel Real-Time in Vivo Optical Imaging Technologies
3. What Recession? How Biomedical Device Companies Thrived in a Bad Economy
4. Crux Biomedicals IVC Filter Receives CE Mark Approval
5. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
6. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
7. Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™"
8. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
9. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
10. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
11. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... HOUSTON , March 3, 2015  Cyberonics, Inc. ... medical devices for the treatment and management of epilepsy, ... Healthcare Conference on Wednesday, March 11, 2015, in ... , Cyberonics, President and Chief Executive Officer, will speak ... conducted in a fireside chat format, and no formal ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., ... cell-derived islet replacement therapy for the treatment of diabetes ... Eugene Brandon , Director of Strategic Relations and ... summit showcases the latest in type 1 diabetes management ... are as follows: , , , Title:   ...
(Date:3/3/2015)... , March 3, 2015  Cannabis Science, Inc. (OTCQB: ... cannabis-based medicine, today announced two important developments: It launched ... global product launches, and CEO Raymond C. Dabney ... HR Examiner. In the article, Dabney answers ... leading a company in an industry that is too ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
... announced that Xeomin ® (incobotulinumtoxinA), a new botulinum toxin ... (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN ... on July 30, 2010. XEOMIN is a botulinum ... is FDA-approved for the treatment of adults with cervical dystonia, ...
... 5 Lixte Biotechnology Holdings (OTC: ... Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), ... Cancer Institute (NCI), National Institutes of Health (NIH), ... collaboration with Lixte Biotechnology Holdings, Inc. for clinical ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 2Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 3Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 4Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 5Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 6Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 2Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... Vancouver, BC (PRWEB) March 03, 2015 ... iData Research ( http://www.idataresearch.com ), market saturation has ... of care in the United States. Unit sales ... continue to increase as facilities replace older systems, ... neurosurgery navigation system market is very much a ...
(Date:3/3/2015)... Celestix Networks, the leading provider of ... global availability of Celestix Cloud Edge Security Appliance ... deployed platform for DirectAccess and remote access roles ... release enables organizations to manage the Windows® Server ... HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... the blues? There’s nothing like getting down and dirty say ... ,The study led by Dr. Chris Lowry ... Mycobacterium vaccae, can actually replicate the effects of anti- depressant ... of lung cancer patients who were treated with the ...
... at those simple, inexpensive, often boisterous bistros that made Paris ... ,The reason is that a number of young chefs, ... to exercise their talents in the casual atmosphere of a ... of vying for a Michelin star. ,As a ...
... California, San Diego (UCSD) School of Medicine have discovered ... with increased clotting of the blood, which has previously ... published in the March issue of CHEST, the official ... ,'In previous work, we have found that sleep ...
... be hailed as a leprosy-free zone by health administrators worldwide. ... more are suffering// from the terrifying disease. ,But ... point out. And the stigma the disease carries with it ... an ancient, much feared disease. But although it is infectious ...
... showing actors blowing glorious rings of smoke or village ... reach for those below 18 years//. ,An ... against tobacco consumption has suggested that films showing smoking ... ,Public Health Foundation of India (PHFI), an autonomous ...
Cached Medicine News:Health News:Be Happy- Get On Your Knees And Play In The Mud 2Health News:'Bistronomy' is Conquering Dining in Paris 2Health News:'Bistronomy' is Conquering Dining in Paris 3Health News:Indian Films With Smoking Scenes may Get 'A' Certificate 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: